Molecular Partners AG (MOLN)
NASDAQ·Healthcare·Biotechnology
$4.12
+4.83%
Mkt Cap $183.26M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$13.00
Range $13.00 – $13.00
Implied Upside
+215.5%
Consensus $13.00 vs current $4.12
NASDAQ·Healthcare·Biotechnology
$4.12
+4.83%
Mkt Cap $183.26M
No recent rating data.
Price Target (2 analysts)
$13.00
Range $13.00 – $13.00
+215.5%
Consensus $13.00 vs current $4.12